Labcorp, an American testing laboratories company, said that its board of directors has authorized it to undertake a spin-off of its fully-owned clinical development business to its shareholders via a tax-free deal. The proposed spin-off will result in a couple of standalone, publicly traded firms, which will be Labcorp, a global laboratory business, and the […]
Labcorp, a North Carolina-based life sciences company, has agreed to acquire Personal Genome Diagnostics (PGDx), a provider of liquid biopsy and tissue-based genomic products and services, in a deal worth up to $575 million. According to Labcorp, the Maryland-based Personal Genome Diagnostics alongside its technology complements and expedites its existing liquid biopsy capabilities and grows […]